|

Low Load Blood Flow Restriction Resistance Training in Colorectal Cancer Related Sarcopenia

RECRUITINGN/ASponsored by Ahmed Adel Ahmed Elsayed Ali Radwan
Actively Recruiting
PhaseN/A
SponsorAhmed Adel Ahmed Elsayed Ali Radwan
Started2026-05-17
Est. completion2027-08-15
Eligibility
Age40 Years – 59 Years
Healthy vol.Accepted

Summary

PURPOSE: To investigate the effects of low-load resistance training combined with blood flow restriction on muscle strength, functional performance, and cancer-related fatigue in colorectal cancer survivors with probable sarcopenia. BACKGROUND: Muscle weakness and cancer-related fatigue are prevalent in colorectal cancer survivors with probable sarcopenia and are associated with adverse outcomes. High-load resistance training is often poorly tolerated in this population. Although low-load resistance training with blood flow restriction shows promise, colorectal cancer-specific randomized evidence remains limited. HYPOTHESES: It is hypothesized that low-load blood flow restriction resistance training will lead to significant improvements in muscle strength and functional performance and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia. RESEARCH QUESTION: Does low-load blood flow restriction resistance training lead to significant improvements in muscle strength and functional performance and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia?

Eligibility

Age: 40 Years – 59 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Colorectal cancer with probable sarcopenia.
2. Age 40-59 years.
3. Low muscle strength defined by EWGSOP2 criteria using the five-times sit-to-stand test (\>15 seconds without upper limb support).
4. Current chemotherapy/radiotherapy or postoperative status with confirmed medical stability.
5. Medical clearance for supervised exercise.
6. Ability to follow instructions and complete assessments.

Exclusion Criteria:

1. Any contraindication to resistance or blood flow restriction training.
2. Uncontrolled cardiovascular disease or hypertension.
3. Recent thromboembolic events.
4. Severe peripheral vascular disease.
5. Uncontrolled treatment-related complications, such as severe anemia or infection.
6. Metastatic bone disease in the lower limbs.
7. Neurological or musculoskeletal disorders limiting safe participation.

Conditions2

CancerColorectal Cancer Survivors

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.